Erratum: Corrigendum: Identification of Two Novel Chlorotoxin Derivatives CA4 and CTX-23 With Chemotherapeutic and Anti-Angiogenic Potential

Scientific Reports - United Kingdom
doi 10.1038/srep26630
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Comparative Evaluation of Anti-Angiogenic Effects of Noscapine Derivatives

Bioinformation
2018English

Anti-Angiogenic Activities of Novel Isocoumarins, AGI-7 and Sescandelin.

Journal of Antibiotics
Drug DiscoveryPharmacology
2001English

Erratum: Corrigendum: Identification of Novel Genes and Pathways in Carotid Atheroma Using Integrated Bioinformatic Methods

Scientific Reports
Multidisciplinary
2016English

Anti-Angiogenic Effects of the Tubulysin Precursor Pretubulysin and of Simplified Pretubulysin Derivatives

British Journal of Pharmacology
Pharmacology
2012English

Evaluation of Novel Chalcone-Thiosemicarbazones Derivatives as Potential Anti-Leishmania Amazonensis Agents and Its HSA Binding Studies

Biomolecules
BiochemistryMolecular Biology
2019English

Biomarkers of Intrinsic Angiogenic and Anti-Angiogenic Activity in Patients With Endometrial Hyperplasia and Endometrial Cancer

Acta Oncologica
Nuclear MedicineRadiologyHematologyOncologyMedicineImaging
2001English

Pharmacological Characteristics and Efficacy of a Novel Anti-Angiogenic Antibody FD006 in Corneal Neovascularization

BMC Biotechnology
Biotechnology
2014English

Synthesis, Characterization and Anti-Inflammatory Evaluation of Novel Derivatives of Trolox With Pharmacological Alcohol and Amines

Bulletin of the Chemical Society of Ethiopia
Chemistry
2017English

Synthesis and Biological Evaluation of Novel Furozan-Based Nitric Oxide-Releasing Derivatives of Oridonin as Potential Anti-Tumor Agents

Molecules
Organic ChemistryMolecular MedicineAnalytical ChemistryTheoretical ChemistryPharmaceutical ScienceMedicineDrug DiscoveryChemistryPhysical
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy